Related references
Note: Only part of the references are listed.Cytoskeletal adaptivity regulates T cell receptor signaling
Timothy J. Thauland et al.
SCIENCE SIGNALING (2017)
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
Venessa T. Chin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Cytoskeletal adaptivity regulates T cell receptor signaling
Timothy J. Thauland et al.
SCIENCE SIGNALING (2017)
Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming
Xiuting Liu et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
A Compact Whole-Eye Perfusion System to Evaluate Pharmacologic Responses of Outflow Facility
Enhua H. Zhou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Advanced MRI Techniques in the Monitoring of Treatment of Gliomas
Harpreet Hyare et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2017)
Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
Yangbo Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine
Hiroyuki Takeda et al.
ANTICANCER RESEARCH (2016)
ABC transporters at the blood-brain barrier
Anne Mahringer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas
Simona Daniele et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Role of CD44 and ERM Proteins in Expression and Functionality of P-glycoprotein in Breast Cancer Cells
Deep Pokharel et al.
MOLECULES (2016)
Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention
Annapurna Pranatharthi et al.
STEM CELLS INTERNATIONAL (2016)
Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2
Yuki Hosokawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
RhoGTPases - A novel link between cytoskeleton organization and cisplatin resistance
Daphna Mokady et al.
DRUG RESISTANCE UPDATES (2015)
Abnormal Wnt signaling and overexpression of ABCG2 contributes to drug efflux properties of side population cells in nasopharyngeal carcinoma
Guo-Fang Guan et al.
MOLECULAR MEDICINE REPORTS (2015)
Multidrug Efflux Pumps Attenuate the Effect of MGMT Inhibitors
Karl-Heinz Tomaszowski et al.
MOLECULAR PHARMACEUTICS (2015)
Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-glycoprotein by Anti-cancer Drugs
Takuro Kobori et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2015)
Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme
Amanda Tivnan et al.
FRONTIERS IN NEUROSCIENCE (2015)
ROCK Inhibition Facilitates In Vitro Expansion of Glioblastoma Stem-Like Cells
Samantha G. Tilson et al.
PLOS ONE (2015)
Differential role of P-glycoprotein and breast cancer resistance protein in drug distribution into brain, CSF and peripheral nerve tissues in rats
Liyue Huang et al.
XENOBIOTICA (2015)
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
Fan Lin et al.
CLINICAL CANCER RESEARCH (2014)
ABC transporters as differentiation markers in glioblastoma cells
Ana R. Rama et al.
MOLECULAR BIOLOGY REPORTS (2014)
Temozolomide Induces the Production of Epidermal Growth Factor to Regulate MDR1 Expression in Glioblastoma Cells
Jessian L. Munoz et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells
Xiaojun Wen et al.
PLOS ONE (2014)
Ocular hypotensive efficacy, safety and systemic absorption of AR-12286 ophthalmic solution in normal volunteers
Casey Kopczynski et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Moesin Is a Glioma Progression Marker That Induces Proliferation and Wnt/β-Catenin Pathway Activation via Interaction with CD44
Xiaoping Zhu et al.
CANCER RESEARCH (2013)
Time-dependent changes in the activation of RhoA/ROCK and ERM/p-ERM in the increased expression of intestinal P-glycoprotein by repeated oral treatment with etoposide
Takuro Kobori et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme
Leroi V. DeSouza et al.
MOLECULAR CANCER (2013)
Activated ERM Protein Plays a Critical Role in Drug Resistance of MOLT4 Cells Induced by CCL25
Li Zhang et al.
PLOS ONE (2013)
Temozolomide-related idiosyncratic and other uncommon toxicities: a systematic review
Sanjay Dixit et al.
ANTI-CANCER DRUGS (2012)
Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1alpha in human ovarian cancer cells
Tsuyoshi Ohta et al.
CANCER BIOLOGY & THERAPY (2012)
Study of chemoresistant CD133+cancer stem cells from human glioblastoma cell line U138MG using multiple assays
Sudha Warrier et al.
CELL BIOLOGY INTERNATIONAL (2012)
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
Xing Gong et al.
NEUROLOGY (2011)
Novel ocular antihypertensive compounds in clinical trials
June Chen et al.
CLINICAL OPHTHALMOLOGY (2011)
Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity
Mutsuki Amano et al.
CYTOSKELETON (2010)
Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells
James M. Angelastro et al.
MOLECULAR CANCER RESEARCH (2010)
HDMX regulates p53 activity and confers chemoresistance to 3-Bis(2-chloroethyl)-1-nitrosourea
Genglin Jin et al.
NEURO-ONCOLOGY (2010)
EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
Bipasha Mukherjee et al.
CANCER RESEARCH (2009)
Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells
Seiji Ogata et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Lack of ABCG2 Expression and Side Population Properties in Human Pluripotent Stem Cells
Hui Zeng et al.
STEM CELLS (2009)
Cytoskeleton and apoptosis
Olivia Ndozangue-Touriguine et al.
BIOCHEMICAL PHARMACOLOGY (2008)
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier
Sandrine Dauchy et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Evidence of galectin-1 involvement in glioma chemoresistance
Marie Le Mercier et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Mechanisms of disease: temozolomide and glioblastoma - look to the future
Maciej M. Mrugala et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Effects of topical administration of Y-39983, a selective Rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys
Hideki Tokushige et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
MRI measurement of the uptake and retention of motexafin gadolinium in glioblastoma multiforme and uninvolved normal human brain
Genevieve N. Wu et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain
E Aronica et al.
EPILEPSIA (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Expression and functional characterization of ABCG2 in brain endothelial cells and vessels
WD Zhang et al.
FASEB JOURNAL (2003)
Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells
AV Somlyo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain
MA Pearson et al.
CELL (2000)